Showing 421-430 of 797 results for "".
Conference Digest: Insights from Summer Neurology Meetings
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/conference-digest-insights-from-summer-neurology-meetings/30335/Emerging Research Can Aid Therapeutic Development
https://practicalneurology.com/diseases-diagnoses/imaging-testing/emerging-research-can-aid-therapeutic-development/30728/Previews of exclusive online content from PracticalNeurology.net- Newshttps://practicalneurology.com/columns/practice-management/news/30775/Recent Advances in Neurology: Key Highlights from Practical Neurology May/June 2012A spectrum of promising developments in neurology were highlighted in the May/June 2012 issue of *Practical Neurology*, offering new insights and potential treatments for conditions such as Alzheimer’s disease, multip
- Leaving AEDs Behind: When to Withdraw Therapy in Seizure-free Patientshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn1008_04-pdf/30980/Managing Antiepileptic Drug (AED) Therapy in Seizure-Free Patients: Key ConsiderationsAchieving complete seizure control is the primary objective in epilepsy management, significantly improving patient quality of life. In specific epilepsy syndromes, such as benign rolandic epilepsy (childhood epile
- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31052/Wernicke Encephalopathy: Recognizing and Managing Thiamine Deficiency in Clinical PracticeWernicke encephalopathy (WE) remains a critical neurological emergency, predominantly affecting individuals with chronic alcoholism but also seen in various other conditions such as malignancies, bariatric surg
- Moving Past Conventional Wisdom in AD Therapyhttps://practicalneurology.com/columns/practice-management/moving-past-conventional-wisdom-in-ad-therapy/31124/Recent advancements in Alzheimer's Disease (AD) treatment are unveiling innovative approaches beyond traditional methods, as highlighted in Practical Neurology's latest News Briefs. Baxter International has reported promising outcomes from its phase II trial of gammagard IVIg, an immunomodulatory th
- Can We Boost The Efficacy of Dopaminergic Therapy?https://practicalneurology.com/columns/practice-management/can-we-boost-the-efficacy-of-dopaminergic-therapy/31220/Parkinson’s disease (PD) management continues to prioritize maintaining patients' quality of life and motor function, aligning with the foundational goals established since Dr. James Parkinson’s initial descriptions in 1817. Contemporary treatment primarily focuses on dopamine replacement to counter
- The Good, the Bad and the Ugly of Alternative Medicinehttps://practicalneurology.com/columns/practice-management/the-good-the-bad-and-the-ugly-of-alternative-medicine/31299/Alternative Medicine in Neurology: Navigating Patient Use and Clinical ImplicationsThe June 2006 issue of *Practical Neurology* addresses the rising prominence of alternative medicine within the neurological patient population, underscored by the bestselling yet controversial book by Kevin Trudeau.
Botox for Chronic Migraine: Tips and Tricks
https://practicalneurology.com/diseases-diagnoses/headache-pain/botox-for-chronic-migraine-tips-and-tricks/30277/Ten Questions for Andrew M. Blumenfeld, MDNeuromodulation Therapies for Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/neuromodulation-therapies-for-headache/31517/Neuromodulation devices creates potential paradigm shift in headache medicine.